// App-Quantinova.ai

2292 : Dipyridamole Induced Headache Indicates Lower Recurrence Risk in Secondary Prevention of Ischemic Stroke

Researchers

Presenter

  • Ralph Sacco

Principal Investigators

  • Salim Yusuf

  • Dan Cotton

  • Philip B Gorelick

  • Philip Bath

  • Richard B Lipton

  • Giora Davidai

Medical Centers

  • Neurology, Univ Hosp Essen, Essen, Germany

  • Miller Sch of Med, Univ of Miami, Miami, FL

  • Inst of Neuroscience, Univ of Nottingham, Nottingham, United Kingdom

  • Mc Master Univ, Population Health Res Inst, Hamilton, ON, Canada

  • Dept of Neurology and Rehabilitation, Univ of Illinois Coll of Med, Chicago, IL

  • Dept of Neurology, Albert Einstein Coll of Med, New York, NY

Locations

  • United States

  • Germany

  • United Kingdom

  • Canada

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

  • Migraine

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • dipyridamole

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved